Dopaminergic treatment modulates sensory attenuation at the onset of the movement in Parkinson's disease: A test of a new framework for bradykinesia. (2016)

First Author: Macerollo A

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/mds.26493

PubMed Identifier: 26749120

Publication URI: http://europepmc.org/abstract/MED/26749120

Type: Journal Article/Review

Volume: 31

Parent Publication: Movement disorders : official journal of the Movement Disorder Society

Issue: 1

ISSN: 0885-3185